[1]
T. Kandelouei and M. Vaezjalali, “Investigation of Relative Risk Factors of Hepatitis B Virus Core Antibody Positivity among Intravenous Drug Users in Tehran, 2013”, Novel Biomed, vol. 5, no. 2, pp. 65–70, Apr. 2017.